Shinya Yokoyama

Nagoya University

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (15)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (3)

shungo adachi

National Institute of Advanced Industrial Science and Technology (AIST)

JAPAN

View details

Teiji Kuzuya

Fujita Health University

JAPAN

View details

Hidenori Tani

Associate Professor

Yokohama University of Pharmacy

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Shinya Yokoyama

Research Interests

Explore related searches

Contact this professor

Articles (15)

Impact of alcohol consumption and muscle mass on bone mineral density in metabolic dysfunction and alcohol-associated liver disease (MetALD) and metabolic dysfunction-associated steatotic liver disease (MASLD)

Soluble Siglec-9 Improves Intestinal Barrier Function in a Mouse Model of Metabolic Dysfunction-Associated Steatohepatitis

Clinical features and pathological findings by liver biopsy in patients with immune-related sclerosing cholangitis induced by immune checkpoint inhibitors

Hepatic Artery Aneurysm Rupture After Double‐Balloon Endoscopy in Biliary Atresia

Identification of Two Long Noncoding RNAs, Kcnq1ot1 and Rmst, as Biomarkers in Chronic Liver Diseases in Mice

Reply - Letter to the editor

Predicting early rebleeding and mortality after endoscopic hemostasis of esophagogastric varices: Diagnostic performance of aspartate aminotransferase‐to‐platelet ratio index and model for end‐stage liver disease‐Na score

Risk factors for decreased bone mineral density in patients with metabolic dysfunction-associated steatotic liver disease: A cross-sectional study at a health examination center

Intestinal Microbiome Associated with Efficacy of Atezolizumab and Bevacizumab Therapy for Hepatocellular Carcinoma

A new criterion including the aspartate aminotransferase‐to‐platelet ratio index and liver and spleen stiffness to rule out varices needing treatment in children with biliary atresia: Modification of the Baveno VII criteria

A Proposal for a Simple Subclassification of Advanced Hepatocellular Carcinoma in Systemic Treatment

Proteomic Analysis Reveals Changes in Tight Junctions in the Small Intestinal Epithelium of Mice Fed a High-Fat Diet

Clustering using unsupervised machine learning to stratify the risk of immune‐related liver injury

Endoscopic injection sclerotherapy with polidocanol for cardiac varices in children and adolescents

The presence of high‐risk varices after sclerotherapy in biliary atresia

Collaborators (3)

shungo adachi

Teiji Kuzuya

Hidenori Tani

Make your next move.